Expression of PCNA, MMP-9, p53, Bax and Bcl-2 in canine transmissible venereal tumors

In conclusion, we thought that the mentioned markers are very useful for understanding the prognosis of TVT, the tumor aggressiveness and the survival of the malignant cells.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:In this study, we aimed to evaluate the proliferative, metastatic and apoptotic capacities of TVT cases, which are in various phases of development, by using immunohistochemical markers.

📊

Key Findings & Data:The material of this study consisted of twelve female and six male dogs diagnosed with TVT brought to our department between 2007 and 2020 years.

💡

Conclusion & Impact:In conclusion, we thought that the mentioned markers are very useful for understanding the prognosis of TVT, the tumor aggressiveness and the survival of the malignant cells.

🔬Design:Research Article

📍Scope:2007 Verileri

⚙️Variables:apoptosis · metastasis · prolfieration

Abstract

In this study, we aimed to evaluate the proliferative, metastatic and apoptotic capacities of TVT cases, which are in various phases of development, by using immunohistochemical markers. The material of this study consisted of twelve female and six male dogs diagnosed with TVT brought to our department between 2007 and 2020 years. Diff-quick staining was applied to the smear taken from tumoral masses for cytological examinations. Tumoral tissues from dogs were fixed in a 10% neutral buffered formaldehyde solution. After routine tissue procedures Hematoxylin & Eosin stain was applied to the sections. Tissue sections were investigated under a light microscope and photographed. Immunohistochemical staining was performed on the tissues using the avidin-biotin immune peroxidase complex method. As a result of macroscopic, cytological and histopathological examinations, TVT positive cases were divided into three according to their developmental stages. While the expression of PCNA, MMP-9, mutant p53 and Bcl-2 increased significantly in progressive cases compared to regressive and stable cases, Bax expression increased significantly in regressive cases compared to progressive and stable cases. In conclusion, we thought that the mentioned markers are very useful for understanding the prognosis of TVT, the tumor aggressiveness and the survival of the malignant cells.

Keywords

apoptosis metastasis prolfieration tvt

🔖

Cite This Article

KARAKURT, E., KURU, M., DAĞ, S., BEYTUT, E., NUHOĞLU, H., DEMİR, M. C., KAÇAR, C., KARATAŞ, Ö., YILDIZ, A. (2020). Expression of PCNA, MMP-9, p53, Bax and Bcl-2 in canine transmissible venereal tumors. Journal of Istanbul Veterinary Sciences, Cilt: 4 - Sayı: 1, 13–20. https://ajindex.com/articles/229578

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Referans1Akkoc, A., Nak, D., Demirer, A., Şimşek, G. (2017). Immunocharacterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 in canine transmissible venereal tumors. Biotechnic & Histochemistry, 92 (2), 100-106. Referans2Alzate, J. M., Montoya-Florez, L. M., Pérez, J.E., Rocha, N. S., Pedraza-Ordonez, F. J. (2019). The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors. Veterinary Clinical Pathology, 48 (4), 730-739. Referans3Aresu, L., Giantin, M., Morello, E., Vascellari, M., Castagnaro, M., Lopparelli, R., Zancanella, V., Granato, A., Garbisa, S., Aricò, A., Bradaschia, A., Mutinelli, F., Dacasto, M. (2011). Matrix metalloproteinases and their inhibitors in canine mammary tumors. BMC Veterinary Research, 7, 33. Referans4Chu, R. M., Lin, C. Y., Liu, C. C., Yang, S. Y., Hsiao, Y. W., Hung, S. W., Pao, H. N., Liao, K.W. (2001). Proliferation characteristics of canine transmissible venereal tumor. Anticancer Research. 21 (6A), 4017-4024. Referans5Coskan, A.S., Alcigir, M. E., Atalay Vural, S. (2011). Pathomorphological and immunohistochemical findings in a case of extragenital canine transmissible venereal tumour. Bulgarian Journal of Veterinary Medicine, 14 (4), 252-256. Referans6Flórez, M.M., Fêo, H. B., da Silva, G. N., Yamatogi, R. S., Aguiar, A. J., Araújo Jr, J. P., Rocha, N. S. (2017). Cell cycle kinetics, apoptosis rates and gene expressions of MDR-1, TP53, BCL-2 and BAX in transmissible venereal tumour cells and their association with therapy response. Veterinary and Comparative Oncology, 15 (3), 793-807 Referans7Gerardi, D. G., Tinucci-Costa, M. Silveira, A. C. T., Moro, J. V. (2014). Expression of P-glycoprotein, multidrug resistance-associated protein, glutathione-S-transferase pi and p53 in canine transmissible venereal tumor. Pesquisa Veterinária Brasileira, 34 (1), 71-78. Referans8Gupta, K. & Sood, N. K. (2012). Pathological and immunohistochemical studies on rare cases of primary extra-genital transmissible venereal tumours in the mammary gland. Veterinarni Medicina, 57 (4), 198-206. Referans9Guvenc, T., Haligur, M., Orman, M.N., Haziroglu, R. (2002). Mitosis and apoptosis in canine cutaneous histiocytoma and transmissible venereal tumour. Acta Veterinaria Hungarica, 50 (3), 315-321. Referans10Lima, C. R. O., Faleiro, M. B. R., Rabelo, R. E., Vulcani, V. A. S., Rubini, M. R., Torres, F. A